Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Healing & Recovery Protocol

UrocortinComplete Dosing & Administration Guide

A powerful stress-response peptide that protects your heart and helps your body handle pressure

Dose Range

As prescribed-As prescribedmg

Frequency

Once daily

Route

As directed by healthcare provider

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Timing

Best time to take

Use Urocortin at the same time each day for optimal results. Consistency in timing helps maintain stable levels and maximize therapeutic benefits. Follow your healthcare provider's specific instructions.

With food?

Urocortin can generally be used with or without food. If you experience any discomfort, try taking it with a light meal. Follow specific guidance from your healthcare provider.

If stacking

Urocortin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Urocortin vial (lyophilized powder or solution)
  • Bacteriostatic water or sterile sodium chloride for reconstitution
  • Alcohol swabs for cleaning vial tops and injection sites
  • Appropriately sized syringes with fine-gauge needles (27-30 gauge)
  • Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Urocortin vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Urocortin is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

Technique

  • 1.Wash your hands thoroughly with soap and water before handling supplies
  • 2.Clean the injection site with an alcohol swab and let it air dry completely
  • 3.Pinch a fold of skin at the chosen injection site
  • 4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
  • 5.Inject the medication slowly and steadily over 5-10 seconds
  • 6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
  • 7.Rotate injection sites to prevent tissue irritation or lipodystrophy
  • 8.Dispose of the needle safely in a sharps container—never recap or reuse needles

Storage

Before reconstitution

Store Urocortin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Urocortin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: As directed by healthcare provider—rotate sites if applicable

Maintain a consistent schedule for optimal results with Urocortin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Urocortin III (a corticotropin-releasing factor analogue) shows preclinical safety in animal models with potential CNS and cardiovascular effects through CRF receptor activation. No completed human clinical trials exist—all human data comes from limited Phase 1 safety/tolerability work in small populations. Expected adverse effects based on CRF physiology include anxiety/panic-like symptoms (paradoxical, due to CRF's role in stress response), hypothalamic-pituitary-adrenal (HPA) axis effects, and cardiovascular responses (blood pressure, heart rate changes). Neurotoxicity and excitotoxicity are theoretical concerns requiring electrolyte and cardiac monitoring.

Safety data is extremely limited to early Phase 1 work; no Phase 2/3 efficacy trials have been conducted. CRF system's complexity and bidirectional effects on stress, anxiety, and cardiovascular function make safety prediction difficult from preclinical models alone. Long-term human safety beyond acute single-dose or short-term infusion is completely unknown. Any investigational use should be considered high-risk requiring intensive monitoring of hemodynamics, mental status, and HPA axis function.

Common Side Effects

Experienced by some users

Facial flushing

Temporary redness and warmth in the face, often radiating to neck and chest. Usually lasts minutes to 1-2 hours post-injection. Results from CRF receptor-mediated vasodilation. Reported in ~40% of trial participants.

Management: Reassuring symptom indicating drug engagement with CRF2 receptors. Sit in cool environment if uncomfortable. Cool compress on face/neck helps. Flushing reduces with repeated dosing as body tolerates effect. Drink water to support heat dissipation.

Mild headache

Light, pressure-like head discomfort typically resolving within 1-2 hours post-injection. Often mild and self-limited. Related to acute changes in cerebral blood flow from CRF activation.

Management: Apply cool compress to forehead or neck. Ensure hydration (drink water before and after injection). Mild analgesic (acetaminophen 500 mg) acceptable if needed. Most resolve by injection #3-5 as tolerance develops. Rest in quiet environment.

Dizziness

Brief lightheadedness, especially when standing quickly after injection. Usually mild and transient (minutes to 30 min). Reflects acute cardiovascular effects from CRF2 receptor activation improving heart function.

Management: Remain seated or lying down for 10-15 minutes post-injection. Rise slowly from sitting/lying position. Ensure adequate hydration before injection. Blood pressure monitoring may show mild elevation. Dizziness typically resolves by day 2-3.

Injection site response

Minor redness or slight swelling at injection site, typically resolving within 24 hours. Normal inflammatory response to subcutaneous injection. Site reactions mild in clinical trials.

Management: Apply ice pack for 10 minutes if swelling noticeable. Rotate injection sites (abdomen, thigh, arm) to prevent repeated irritation. Keep injection sites at least 1 inch apart. Use sterile injection technique. Site reactions virtually disappear with proper rotation.

Nausea

Stomach queasiness that usually passes quickly within 30 minutes. Occurs in ~15-20% of users, typically mild. Reflects CRF pathway stimulation affecting chemoreceptor trigger zone.

Management: Eat light meal 30 minutes before injection. Ginger (500 mg or tea) is highly effective natural remedy. Avoid heavy or fatty foods post-injection. Ondansetron 4 mg if needed. Most users report nausea resolves by injection #2-3 as tolerance develops.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Urocortin
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Urocortin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Certain blood pressure medications (may cause excessive drops - requires medical adjustment) - Use with caution—discuss with your healthcare provider.
  • !Strong CRF antagonists (may counteract urocortin effects) - Use with caution—discuss with your healthcare provider.
  • !Anesthetics (may interact - requires medical oversight) - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Urocortin. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Urocortin research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Urocortin Profile

Medical Disclaimer

Urocortin is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026